<p>Opthea Limited Sponsored ADR (OPT) 的最新公告已发布。</p>
<p>Opthea Limited 宣布将于 2025 年 11 月 11 日召开即将举行的年度股东大会，会议将以虚拟形式进行。主要议程包括重新选举董事 Dr. Jeremy Levin 和 Ms. Kathy Connell，采纳薪酬报告，以及根据公司的激励计划发行期权。这些决议预计将影响 Opthea 的治理和薪酬结构，可能对股东价值和公司战略产生影响。</p>
<p>(OPT) 股票的最新分析师评级为持有，目标价格为 1.00 美元。要查看关于 Opthea Limited Sponsored ADR 股票的完整分析师预测列表，请访问 OPT 股票预测页面。</p>
<p><strong>Spark 对 OPT 股票的看法</strong></p>
<p>根据 Spark，TipRanks 的 AI 分析师，OPT 被评为表现不佳。</p>
<p>由于面临重大财务挑战，包括持续亏损、高杠杆和糟糕的现金流管理，Opthea Limited 的股票目前评级较低。技术分析显示出看跌趋势，没有立即的复苏信号。估值指标不利，市盈率为负且没有股息收益，表明对寻求增长或收入的投资者吸引力有限。该股票的高贝塔值增加了风险特征，强调了需要战略性改进以提升财务表现。</p>
<p>要查看 Spark 关于 OPT 股票的完整报告，请点击这里。</p>
<p><strong>关于 Opthea Limited Sponsored ADR 的更多信息</strong></p>
<p>Opthea Limited 在生物技术行业运营，专注于眼病治疗的开发。该公司主要致力于推进湿性年龄相关性黄斑变性和糖尿病性黄斑水肿等疾病的治疗，旨在满足眼科领域的重大未满足需求。</p>
<p><strong>技术情绪信号：</strong> 卖出</p>
<p><strong>当前市值：</strong> 4.852 亿美元</p>
<p>要深入了解 OPT 股票，请访问 TipRanks 的概述页面。</p>

OPTEY

<p>Opthea Limited 已安排于 2025 年 11 月 11 日召开虚拟年度股东大会。主要议程包括董事的重新选举和薪酬报告的通过。最新的分析师评级为 OPT 股票持有，目标价格为 1.00 美元，而 Spark 的 AI 分析师则因财务挑战将其评级为表现不佳。该股票显示出看跌趋势，估值指标不利且贝塔值较高，表明需要进行战略改进。Opthea 专注于开发眼病治疗药物，目前市值为 4.852 亿美元</p>

<p>The latest announcement is out from Opthea Limited Sponsored ADR ( (OPT) ).</p>
<div class="lb-trans"><p>Opthea Limited Sponsored ADR (OPT) 的最新公告已发布。</p>
</div><p>Opthea Limited has announced its upcoming Annual General Meeting, scheduled for November 11, 2025, which will be held virtually. Key agenda items include the re-election of directors Dr. Jeremy Levin and Ms. Kathy Connell, the adoption of the remuneration report, and the issuance of options under the company’s incentive plans. These resolutions are expected to influence Opthea’s governance and compensation structure, potentially impacting shareholder value and company strategy.</p>
<div class="lb-trans"><p>Opthea Limited 宣布将于 2025 年 11 月 11 日召开即将举行的年度股东大会，会议将以虚拟形式进行。主要议程包括重新选举董事 Dr. Jeremy Levin 和 Ms. Kathy Connell，采纳薪酬报告，以及根据公司的激励计划发行期权。这些决议预计将影响 Opthea 的治理和薪酬结构，可能对股东价值和公司战略产生影响。</p>
</div><p>The most recent analyst rating on (OPT) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Opthea Limited Sponsored ADR stock, see the OPT Stock Forecast page.</p>
<div class="lb-trans"><p>(OPT) 股票的最新分析师评级为持有，目标价格为 1.00 美元。要查看关于 Opthea Limited Sponsored ADR 股票的完整分析师预测列表，请访问 OPT 股票预测页面。</p>
</div><p><strong>Spark’s Take on OPT Stock</strong></p>
<div class="lb-trans"><p><strong>Spark 对 OPT 股票的看法</strong></p>
</div><p>According to Spark, TipRanks’ AI Analyst, OPT is a Underperform.</p>
<div class="lb-trans"><p>根据 Spark，TipRanks 的 AI 分析师，OPT 被评为表现不佳。</p>
</div><p>Opthea Limited’s stock is currently rated low due to significant financial challenges, including persistent losses, high leverage, and poor cash flow management. The technical analysis indicates a bearish trend with no immediate recovery signals. Valuation metrics are unfavorable, with a negative P/E ratio and no dividend yield, suggesting limited appeal to investors seeking growth or income. The stock’s high beta adds to the risk profile, emphasizing the need for strategic improvements to enhance financial performance.</p>
<div class="lb-trans"><p>由于面临重大财务挑战，包括持续亏损、高杠杆和糟糕的现金流管理，Opthea Limited 的股票目前评级较低。技术分析显示出看跌趋势，没有立即的复苏信号。估值指标不利，市盈率为负且没有股息收益，表明对寻求增长或收入的投资者吸引力有限。该股票的高贝塔值增加了风险特征，强调了需要战略性改进以提升财务表现。</p>
</div><p>To see Spark’s full report on OPT stock, click here.</p>
<div class="lb-trans"><p>要查看 Spark 关于 OPT 股票的完整报告，请点击这里。</p>
</div><p><strong>More about Opthea Limited Sponsored ADR</strong></p>
<div class="lb-trans"><p><strong>关于 Opthea Limited Sponsored ADR 的更多信息</strong></p>
</div><p>Opthea Limited operates in the biotechnology industry, focusing on the development of therapies for eye diseases. The company is primarily engaged in advancing treatments for conditions such as wet age-related macular degeneration and diabetic macular edema, aiming to address significant unmet needs in ophthalmology.</p>
<div class="lb-trans"><p>Opthea Limited 在生物技术行业运营，专注于眼病治疗的开发。该公司主要致力于推进湿性年龄相关性黄斑变性和糖尿病性黄斑水肿等疾病的治疗，旨在满足眼科领域的重大未满足需求。</p>
</div><p><strong>Technical Sentiment Signal:</strong> Sell</p>
<div class="lb-trans"><p><strong>技术情绪信号：</strong> 卖出</p>
</div><p><strong>Current Market Cap:</strong> $485.2M</p>
<div class="lb-trans"><p><strong>当前市值：</strong> 4.852 亿美元</p>
</div><p>For an in-depth examination of OPT stock, go to TipRanks’ Overview page.</p>
<div class="lb-trans"><p>要深入了解 OPT 股票，请访问 TipRanks 的概述页面。</p>
</div>

Opthea Limited 计划于 2025 年 11 月召开线上年度股东大会